Clinical Trial Update: Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial MK-7119-002 assesses safety and pharmacokinetics of tucatinib (MK-7119) in Chinese participants with cancer; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Tucatinib (tucatinib)

Snippet

Sponsor: Pfizer | Conditions: Metastatic HER2+ Advanced Breast Cancer, Breast Neoplasms | Phase 1 | Status: ACTIVE_NOT_RECRUITING